![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Rexahn Reports ‘Compelling’ Results — and an Explanation
Rexahn Reports ‘Compelling’ Results — and an Explanation
April 16, 2010
Executives at Rexahn Pharmaceuticals envision a wide range of uses for its central nervous system drug Serdaxin, from biodefense to treating Alzheimer’s
disease.
Gazette
Gazette
Upcoming Events
-
21Oct